These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32854439)

  • 41. Vancomycin release behaviour from amorphous calcium polyphosphate matrices intended for osteomyelitis treatment.
    Dion A; Langman M; Hall G; Filiaggi M
    Biomaterials; 2005 Dec; 26(35):7276-85. PubMed ID: 16024076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cholesterol in situ forming gel loaded with doxycycline hyclate for intra-periodontal pocket delivery.
    Phaechamud T; Setthajindalert O
    Eur J Pharm Sci; 2017 Mar; 99():258-265. PubMed ID: 28027940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of inhaled vancomycin hydrochloride on elimination of methicillin-resistant Staphylococcus aureus].
    Shirai M; Ide K; Sato M; Murakami M; Tanaka Y; Sato A; Chida K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1233-9. PubMed ID: 8583715
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of lipidation and glycosylation on short cationic antimicrobial peptides.
    Grimsey E; Collis DWP; Mikut R; Hilpert K
    Biochim Biophys Acta Biomembr; 2020 Aug; 1862(8):183195. PubMed ID: 32130974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Study of antimicrobial effects of vancomycin loaded PLGA nanoparticles against enterococcus clinical isolates.
    Lotfipour F; Abdollahi S; Jelvehgari M; Valizadeh H; Hassan M; Milani M
    Drug Res (Stuttg); 2014 Jul; 64(7):348-52. PubMed ID: 24307271
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phenotypic and genomic comparisons of highly vancomycin-resistant Staphylococcus aureus strains developed from multiple clinical MRSA strains by in vitro mutagenesis.
    Ishii K; Tabuchi F; Matsuo M; Tatsuno K; Sato T; Okazaki M; Hamamoto H; Matsumoto Y; Kaito C; Aoyagi T; Hiramatsu K; Kaku M; Moriya K; Sekimizu K
    Sci Rep; 2015 Nov; 5():17092. PubMed ID: 26603341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nanoparticles as tool for enhanced ophthalmic delivery of vancomycin: a multidistrict-based microbiological study, solid lipid nanoparticles formulation and evaluation.
    Yousry C; Fahmy RH; Essam T; El-Laithy HM; Elkheshen SA
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1752-62. PubMed ID: 27093938
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
    Kranz H; Bodmeier R
    Eur J Pharm Sci; 2008 Jul; 34(2-3):164-72. PubMed ID: 18501569
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics Study.
    Hussein M; Karas JA; Schneider-Futschik EK; Chen F; Swarbrick J; Paulin OKA; Hoyer D; Baker M; Zhu Y; Li J; Velkov T
    mSystems; 2020 May; 5(3):. PubMed ID: 32457238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacist-managed dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillin-resistant
    Hirano R; Sakamoto Y; Kitazawa J; Yamamoto S; Tachibana N
    Infect Drug Resist; 2016; 9():243-252. PubMed ID: 27789965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potency of DX-619, a novel des-F(6)-quinolone, in haematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
    Yanagihara K; Seki M; Izumikawa K; Higashiyama Y; Miyazaki Y; Hirakata Y; Tomono K; Mizuta Y; Tsukamoto K; Kohno S
    Int J Antimicrob Agents; 2006 Sep; 28(3):212-6. PubMed ID: 16887340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activity of daptomycin- and vancomycin-loaded poly-epsilon-caprolactone microparticles against mature staphylococcal biofilms.
    Ferreira IS; Bettencourt AF; Gonçalves LM; Kasper S; Bétrisey B; Kikhney J; Moter A; Trampuz A; Almeida AJ
    Int J Nanomedicine; 2015; 10():4351-66. PubMed ID: 26185439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incorporation of 2-hydroxyl fatty acids by Acinetobacter calcoaceticus RAG-1 to tailor emulsan structure.
    Zhang J; Gorkovenko A; Gross RA; Allen AL; Kaplan D
    Int J Biol Macromol; 1997 Feb; 20(1):9-21. PubMed ID: 9110181
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro testing of a first-in-class tri-alkylnorspermidine-biaryl antibiotic in an anti-biofilm silicone coating.
    Ashton NN; Allyn G; Porter ST; Haussener TJ; Sebahar PR; Looper RE; Williams DL
    Acta Biomater; 2019 Jul; 93():25-35. PubMed ID: 30769135
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of long term lipogenic effects of two different medium-chain triglycerides (tri C8: O and tri C12 : O) in the growing rat.
    Demarne Y; Epo N; Flanzy J; Lecourtier MJ
    Arch Int Physiol Biochim; 1978 Feb; 86(1):25-35. PubMed ID: 80196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vancomycin-triacetyl cyclodextrin interaction products for prolonged drug delivery.
    Ferrari F; Sorrenti M; Rossi S; Catenacci L; Sandri G; Bonferoni MC; Caramella C; Bettinetti G
    Pharm Dev Technol; 2008; 13(1):65-73. PubMed ID: 18300101
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CSA-90 Promotes Bone Formation and Mitigates Methicillin-resistant Staphylococcus aureus Infection in a Rat Open Fracture Model.
    Mills R; Cheng TL; Mikulec K; Peacock L; Isaacs D; Genberg C; Savage PB; Little DG; Schindeler A
    Clin Orthop Relat Res; 2018 Jun; 476(6):1311-1323. PubMed ID: 29698291
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long lasting in-situ forming implant loaded with raloxifene HCl: An injectable delivery system for treatment of bone injuries.
    Elkasabgy NA; Abdel-Salam FS; Mahmoud AA; Basalious EB; Amer MS; Mostafa AA; Elkheshen SA
    Int J Pharm; 2019 Nov; 571():118703. PubMed ID: 31536761
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased drug resistance of meticillin-resistant Staphylococcus aureus biofilms formed on a mouse dermal chip model.
    Jimi S; Miyazaki M; Takata T; Ohjimi H; Akita S; Hara S
    J Med Microbiol; 2017 Apr; 66(4):542-550. PubMed ID: 28463660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In situ forming phase-inversion implants for sustained ocular delivery of triamcinolone acetonide.
    Sheshala R; Hong GC; Yee WP; Meka VS; Thakur RRS
    Drug Deliv Transl Res; 2019 Apr; 9(2):534-542. PubMed ID: 29484530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.